Bolton W K, Scheld W M, Spyker D A, Overby T L, Sande M A
Antimicrob Agents Chemother. 1980 Dec;18(6):933-8. doi: 10.1128/AAC.18.6.933.
We have examined the pharmacokinetics of moxalactam (LY127935) in 36 subjects with various degrees of renal dysfunction. Creatinine clearance (Ccr)/1.73 m2 ranged from zero to 135.8 ml/min. After a 1-g administration of moxalactam intravenously, the volume of distribution was 20.6 /+- 9.5 liters (0.28 liter/kg), and the mean half-life ranged from 3.1 h for subjects with Ccr greater than 65 ml/min to 19.3 h for subjects with Ccr less than 10 ml/min. The moxalactam clearance was closely correlated to Ccr (r = 0.93, P less than 0.0001) and excretion of antibiotic was 73.6 +/- 13% in normal subjects. Renal clearance accounted for 90% of moxalactam clearance in the normal subjects. A dosage schedule for administering moxalactam to patients with various degrees of renal dysfunction is provided.
我们研究了头孢氧哌唑(LY127935)在36例不同程度肾功能不全患者中的药代动力学。肌酐清除率(Ccr)/1.73 m²范围为0至135.8 ml/分钟。静脉注射1克头孢氧哌唑后,分布容积为20.6±9.5升(0.28升/千克),平均半衰期范围从Ccr大于65 ml/分钟的受试者的3.1小时到Ccr小于10 ml/分钟的受试者的19.3小时。头孢氧哌唑清除率与Ccr密切相关(r = 0.93,P小于0.0001),正常受试者中抗生素排泄率为73.6±13%。正常受试者中,肾清除率占头孢氧哌唑清除率的90%。本文提供了针对不同程度肾功能不全患者使用头孢氧哌唑的给药方案。